Cells for New life

Diseases treated with stem cells

Systemic atrophies primarily affecting the central nervous system

  • G10

    Huntington's disease. Includes: Huntington's chorea

  • G11

    Hereditary ataxia

  • G11.0

    Congenital nonprogressive ataxia

  • G11.1

    Early-onset cerebellar ataxia Note: Onset usually by the mid-twenties. Includes: Early-onset cerebellar ataxia with: essential tremor, myoclonus [Hunt's ataxia], retained tendon reflexes. Friedreich's ataxia (autosomal recessive). Machado-Joseph Disease [MJD] spinocerebellar ataxia. X-linked recessive spinocerebellar ataxia

  • G11.2

    Late-onset cerebellar ataxia. Note: Onset usually after the mid-twenties.

  • G11.3

    Cerebellar ataxia with defective DNA repair. Includes: Ataxia telangiectasia [Louis-Bar]

  • G11.4

    Hereditary spastic paraplegia

  • G11.8

    Other hereditary ataxias

  • G11.9

    Hereditary ataxia, unspecified. Includes: Garland-Moorhause syndrome. Hereditary cerebellar: ataxia NOS, degeneration (primary), disease, syndrome. Marinesco-Sjogren syndrome. Torsten syndrome

  • G12

    Spinal muscular atrophy and related syndromes

  • G12.0

    Infantile spinal muscular atrophy, type I [Werdnig-Hoffman]. Includes: Acute [inherited] infantile type I

  • G12.1

    Other inherited spinal muscular atrophy. Includes: Progressive bulbar palsy of childhood [Fazio-Londe]. Spinal muscular atrophy: adult form, childhood form, type II, distal, juvenile form, type III [Kugelberg-Welander], scapuloperoneal form

  • G12.2

    Motor neuron disease. Includes: Familial motor neuron disease. Lateral sclerosis: amyotrophic, primary. Progressive: bulbar palsy, spinal muscular atrophy

  • G12.8

    Other spinal muscular atrophies and related syndromes

  • G12.9

    Spinal muscular atrophy, unspecified

  • G13

    Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere

  • G13.2

    Systemic atrophy primarily affecting central nervous system in myxoedema

  • G14

    Postpolio syndrome. Includes: Postpolio myelitic syndrome. Extrapyramidal and movement disorders

  • G20

    Parkinson's disease. Includes: Hemiparkinsonism, Paralysis agitans, Parkinsonism or Parkinson's disease: NOS, idiopathic, primary

  • G21

    Secondary parkinsonism

  • G21.3

    Postencephalitic parkinsonism

  • G21.4

    Vascular parkinsonism

  • G21.8

    Other secondary parkinsonism

  • G21.9

    Secondary parkinsonism, unspecified

  • G23

    Other degenerative diseases of basal ganglia

  • G23.0

    Hallervorden-Spatz disease. Includes: Pigmentary pallidal degeneration

  • G23.1

    Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]

  • G23.2

    Striatonigral degeneration

  • G23.8

    Other specified degenerative diseases of basal ganglia. Includes: Calcification of basal ganglia

  • G23.9

    Degenerative disease of basal ganglia, unspecified

Oleksandr Kuharchuk

Director of Research Department. EmProCell Privat Limited

Ask professor O. Kuharchuk